Goodarzi E, Moslem A, Feizhadad H, Jarrahi A, Adineh H, Sohrabivafa M, et al. Epidemiology, incidence and mortality of thyroid cancer and their relationship with the human development index in the world: An ecology study in 2018. Advances in Human Biology. 2019;9(2):162-7.
Vaccarella S, Lortet-Tieulent J, Colombet M, Davies L, Stiller CA, Schüz J, et al. Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. The lancet Diabetes & endocrinology. 2021;9(3):144-52.
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer. 2019;144(8):1941-53.
CAS PubMed Article Google Scholar
Rossi ED, Pantanowitz L, Hornick JL. A worldwide journey of thyroid cancer incidence centred on tumour histology. The Lancet Diabetes & Endocrinology. 2021;9(4):193-4.
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.
PubMed PubMed Central Article Google Scholar
American Cancer Society. Thyroid cancer survival rates, by type and stage 2021 January 5 [Available from: https://www.cancer.org/cancer/thyroid-cancer/detection-diagnosis-staging/survival-rates.html.
American Thyroid Association. Thyroid Cancer 2016 [updated 2016. Available from: https://www.thyroid.org/thyroid-cancer/.
Zhao C-K, Xu H-X, Xu J-M, Sun C-Y, Chen W, Liu B-J, et al. Risk stratification of thyroid nodules with Bethesda category III results on fine-needle aspiration cytology: The additional value of acoustic radiation force impulse elastography. Oncotarget. 2017;8(1):1580-92.
Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017;27(11):1341-6.
Yaprak Bayrak B, Eruyar AT. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology. BMC Endocr Disord. 2020;20(1):48-.
Khan TM, Zeiger MA. Thyroid Nodule Molecular Testing: Is It Ready for Prime Time? Front Endocrinol (Lausanne). 2020;11:590128-.
Vishwanath D, Shanmugam A, Sundaresh M, Hariharan A, Saraf S, Bahadur U, et al. Development of a Low-cost NGS Test for the Evaluation of Thyroid Nodules. Indian Journal of Surgical Oncology. 2019.
Armanious H, Adam B, Meunier D, Formenti K, Izevbaye I. Digital gene expression analysis might aid in the diagnosis of thyroid cancer. Curr Oncol. 2020;27(2):e93-e9.
CAS PubMed PubMed Central Article Google Scholar
Cantara S, Marzocchi C, Pilli T, Cardinale S, Forleo R, Castagna MG, et al. Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis. Int J Mol Sci. 2017;18(4):775.
PubMed Central Article CAS Google Scholar
Nair CG, Babu M, Biswas L, Jacob P, Menon R, Revathy AK, et al. Lack of Association of B-type Raf Kinase V600E Mutation with High-risk Tumor Features and Adverse Outcome in Conventional and Follicular Variants of Papillary Thyroid Carcinoma. Indian journal of endocrinology and metabolism. 2017;21(2):329-33.
CAS PubMed PubMed Central Article Google Scholar
Santos MTD, Buzolin AL, Gama RR, Silva E, Dufloth RM, Figueiredo DLA, et al. Molecular Classification of Thyroid Nodules with Indeterminate Cytology: Development and Validation of a Highly Sensitive and Specific New miRNA-Based Classifier Test Using Fine-Needle Aspiration Smear Slides. Thyroid. 2018;28(12):1618-26.
CAS PubMed PubMed Central Article Google Scholar
González HE, Martínez JR, Vargas-Salas S, Solar A, Veliz L, Cruz F, et al. A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study. Thyroid. 2017;27(8):1058-67.
PubMed PubMed Central Article CAS Google Scholar
Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. The Journal of clinical endocrinology and metabolism. 2011;96(11):3390-7.
CAS PubMed PubMed Central Article Google Scholar
Cochand-Priollet B, Dahan H, Laloi-Michelin M, Polivka M, Saada M, Herman P, et al. Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control. Thyroid. 2011;21(10):1067-73.
CAS PubMed Article Google Scholar
Collet JF, Hurbain I, Prengel C, Utzmann O, Scetbon F, Bernaudin JF, et al. Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples. Br J Cancer. 2005;93(10):1175-81.
CAS PubMed PubMed Central Article Google Scholar
Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies. Annals of Internal Medicine. 2011;155(8):529-36.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-34.
CAS PubMed PubMed Central Article Google Scholar
Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455-63.
CAS PubMed Article Google Scholar
Aiad HA, Kandil MA, Asaad NY, El-Kased AM, El-Goday SF. Galectin-3 immunostaining in cytological and histopathological diagnosis of thyroid lesions. J Egypt Natl Canc Inst. 2008;20(1):36-46.
Aratake Y, Umeki K, Kiyoyama K, Hinoura Y, Sato S, Ohno A, et al. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules. Diagnostic cytopathology. 2002;26(6):366-72.
Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. The Lancet. 2001;357(9269):1644-50.
Bartolazzi A, Orlandi F, Saggiorato E, Volante M, Arecco F, Rossetto R, et al. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. The Lancet Oncology. 2008;9(6):543-9.
CAS PubMed Article Google Scholar
Carpi A, Rossi G, Coscio GD, Iervasi G, Nicolini A, Carpi F, et al. Galectin-3 detection on large-needle aspiration biopsy improves preoperative selection of thyroid nodules: a prospective cohort study. Ann Med. 2010;42(1):70-8.
CAS PubMed Article Google Scholar
Ersoz S, Sert H, Yandi M, Erem C, Mungan S, Ersoz HO, et al. The significance of Galectin-3 expression in the immunocytochemical evaluation of thyroid fine needle aspiration cytology. Pathol Oncol Res. 2008;14(4):457-60.
Kim MJ, Kim HJ, Hong SJ, Shong YK, Gong G. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions. Acta Cytol. 2006;50(1):28-34.
Muzafar A, Bukhari MH, Qureshi IU. A study of Galactin-3 on fine needle aspiration as a diagnostic marker differentiating benign from malignant thyroid neoplasm. Pak J Med Sci. 2017;33(3):726-31.
PubMed PubMed Central Article Google Scholar
Papotti M, Volante M, Saggiorato E, Deandreis D, Veltri A, Orlandi F. Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. Eur J Endocrinol. 2002;147(4):515-21.
CAS PubMed Article Google Scholar
Paskas S, Jankovic J, Zivaljevic V, Tatic S, Bozic V, Nikolic A, et al. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing. Cancer Cytopathol. 2015;123(8):471-9.
CAS PubMed Article Google Scholar
Pennelli G, Mian C, Pelizzo MR, Naccamulli D, Piotto A, Girelli ME, et al. Galectin-3 cytotest in thyroid follicular neoplasia: a prospective, monoinstitutional study. Acta Cytol. 2009;53(5):533-9.
Raggio E, Camandona M, Solerio D, Martino P, Franchello A, Orlandi F, et al. The diagnostic accuracy of the immunocytochemical markers in the pre-operative evaluation of follicular thyroid lesions. J Endocrinol Invest. 2010;33(6):378-81.
CAS PubMed Article Google Scholar
Saggiorato E, Cappia S, De Giuli P, Mussa A, Pancani G, Caraci P, et al. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. The Journal of clinical endocrinology and metabolism. 2001;86(11):5152-8.
CAS PubMed Article Google Scholar
Saggiorato E, Aversa S, Deandreis D, Arecco F, Mussa A, Puligheddu B, et al. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas. J Endocrinol Invest. 2004;27(4):311-7.
CAS PubMed Article Google Scholar
Sapio MR, Guerra A, Posca D, Limone PP, Deandrea M, Motta M, et al. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Endocrine-related cancer. 2007;14(4):1089-97.
CAS PubMed Article Google Scholar
Fadda G, Rossi ED, Raffaelli M, Pontecorvi A, Sioletic S, Morassi F, et al. Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology. Eur J Endocrinol. 2011;165(3):447-53.
CAS PubMed Article Google Scholar
Franco C, Martínez V, Allamand JP, Medina F, Glasinovic A, Osorio M, et al. Molecular markers in thyroid fine-needle aspiration biopsy: a prospective study. Appl Immunohistochem Mol Morphol. 2009;17(3):211-5.
CAS PubMed Article Google Scholar
Rossi ED, Straccia P, Martini M, Revelli L, Lombardi CP, Pontecorvi A, et al. The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience. Cancer Cytopathol. 2014;122(5):359-67.
留言 (0)